Different impacts of acylated and non-acylated long-acting insulin analogs on neural functions in vitro and in vivo

Insulin and Gla have greater impacts on central nervous system than insulin analogs with high albumin sensitivity, such as Det and Deg. These pharmacological profiles should be taken into account for developing an insulin-based therapy to treat Alzheimer's disease.